FACTOR V LEIDEN INCREASES THE RISK OF THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES

By Simantov R.   Lo S.K.   Salmon J.E.   Sammaritano L.R.   Silverstein R.L.  

Thrombosis Research, Vol. 84, Iss. 5, 1996-12 ,pp. : 361-365

Elsevier

Access to resources Recommend Favorite

Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis

By van Dunné F.M.  

Human Reproduction, Vol. 20, Iss. 3, 2005-03 ,pp. : 802-806

Oxford University Press

Access to resources Recommend Favorite

A Case Control Study on the Contribution of Factor V-Leiden, Prothrombin G20210A, and MTHFR C677T Mutations to the Genetic Susceptibility of Deep Venous Thrombosis

By Almawi Wassim   Tamim Hala   Kreidy Raghid   Timson Georgina   Rahal Elias   Nabulsi Malak   Finan Ramzi   Irani-Hakime Noha  

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 3, 2005-06 ,pp. : 189-196

Springer Publishing Company

Access to resources Recommend Favorite

Combined severe factor XII deficiency and homozygous factor V Leiden mutation in a patient with venous thrombosis

By Miljic P.   Colovic M.   Rakicevic L.   Djordjevic V.   Boskovic D.  

Thrombosis Research, Vol. 106, Iss. 4, 2002-05 ,pp. : 265-267

Elsevier

Access to resources Recommend Favorite

Prevalence of Factor V 1691 G–A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients

By Eroglu Aydan   Ulu Arzu   Çam Ragip   Kurtman Cengiz   Akar Nejat  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 1, 2007-02 ,pp. : 31-34

Springer Publishing Company

Access to resources Recommend Favorite